Clincosm LogoSign in Get a demo

Pancreatic Neoplasms

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, NSCLC, Pancreatic Tumors Trial in Worldwide (V941, Pembrolizumab)

Completed
  • Neoplasms
  • +3 more
  • V941
  • Pembrolizumab
  • Gilbert, Arizona
  • +25 more
Sep 5, 2022

NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Los Angeles, California
  • +21 more
Jul 22, 2022

Breast Tumors, Pancreatic Tumors Trial in United States (nab-Paclitaxel, Nivolumab, Gemcitabine)

Completed
  • Breast Neoplasms
  • Pancreatic Neoplasms
  • Sacramento, California
  • +14 more
May 29, 2019

Pancreatic Tumors, Pancreatic Cancer, Pancreatitis Trial in United States

Unknown status
  • Pancreatic Neoplasms
  • +4 more
    • Gilbert, Arizona
    • +5 more
    Apr 11, 2019

    Pancreatic Tumors Trial in Worldwide (nab-Paclitaxel, Gemcitabine, Chemoradiation)

    Completed
    Has Results
    • Pancreatic Neoplasms
    • Scottsdale, Arizona
    • +41 more
    Mar 18, 2019

    Pancreatic Tumors, Ovarian Tumors, Breast Tumors Trial in United States (BTP-114)

    Unknown status
    • Pancreatic Neoplasms
    • +3 more
    • Sarasota, Florida
    • +7 more
    Jan 11, 2019

    Pancreatic Tumors, Ovarian Tumors Trial in United States (DMUC4064A)

    Completed
    • Pancreatic Neoplasms
    • Ovarian Neoplasms
    • Sarasota, Florida
    • +6 more
    Jun 20, 2018

    Gastric Tumors, Pancreatic Tumors Trial in United States (ASG-5ME)

    Completed
    • Gastric Neoplasms
    • Pancreatic Neoplasms
    • Scottsdale, Arizona
    • +6 more
    Aug 23, 2013

    Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)

    Completed
    Has Results
    • Islet Cell Carcinoma
    • +3 more
    • Everolimus 10 mg
    • Octreotide Depot
    • Birmingham, Alabama
    • +53 more
    May 6, 2013